Pfizer Notes Doctor Decisions In Appeal Of $142M RICO Award

Law360, New York (February 7, 2013, 7:29 PM EST) -- Pfizer Inc. argued to the First Circuit on Wednesday that physicians' independent decisions to prescribe pain drug Neurontin for off-label uses should take the drugmaker off the hook for a $142 million jury award to HMO operator Kaiser Foundation Health Plan Inc.

Pfizer is seeking to overturn a jury's finding that it violated the Racketeer Influenced and Corrupt Organizations Act by fraudulently marketing Neurontin for off-label use. Kaiser contended that had it known Neurontin was not effective for the claimed off-label uses, it would not have...
To view the full article, register now.